Education
About Us
Working with TipRanks
Follow Us
Biosergen AB (SE:BIOSGN)
:BIOSGN
BIOSGN Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr0.27 - kr1.14
Previous CloseN/A
Volume13.64K
Average Volume (3M)261.65K
Market Cap
kr69.27M
Enterprise Valuekr76.33M
Total Cash (Recent Filing)kr50.61M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta-0.39
Next Earnings
May 29, 2025EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding234,823,210
10 Day Avg. Volume150,367
30 Day Avg. Volume261,650
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Biosergen AB News
---
BIOSGN FAQ
What was Biosergen AB’s price range in the past 12 months?
Biosergen AB lowest stock price was kr0.27 and its highest was kr1.14 in the past 12 months.
What is Biosergen AB’s market cap?
Biosergen AB’s market cap is kr69.27M.
When is Biosergen AB’s upcoming earnings report date?
Biosergen AB’s upcoming earnings report date is May 29, 2025 which is in 32 days.
How were Biosergen AB’s earnings last quarter?
Biosergen AB released its earnings results on Mar 31, 2025. The company reported -kr0.02 earnings per share for the quarter, the consensus estimate of -kr0.02 by kr0.
Is Biosergen AB overvalued?
According to Wall Street analysts Biosergen AB’s price is currently Overvalued.
Does Biosergen AB pay dividends?
Biosergen AB does not currently pay dividends.
What is Biosergen AB’s EPS estimate?
Biosergen AB’s EPS estimate is -0.02.
How many shares outstanding does Biosergen AB have?
Biosergen AB has 234,823,210 shares outstanding.
What happened to Biosergen AB’s price movement after its last earnings report?
Biosergen AB reported an EPS of -kr0.02 in its last earnings report, expectations of -kr0.02. Following the earnings report the stock price went up 11.315%.
Which hedge fund is a major shareholder of Biosergen AB?
Currently, no hedge funds are holding shares in SE:BIOSGN
---
Company Description
Biosergen AB
Biosergen AB (BIOSGN) is a biotechnology company focused on the research and development of novel antifungal therapies. The company operates in the healthcare sector, particularly within the pharmaceutical and biotechnology industries. Its core product pipeline includes innovative antifungal compounds aimed at addressing unmet needs in the treatment of fungal infections.
---
Technical Analysis
Active Biotech AB
―
Biovica International AB Class B
―
PILA PHARMA AB
―
Spago Nanomedical AB
―
---